false--12-31Q22020000031361635000008200000300000030000000.01000.00653050000000.42us-gaap:AccountingStandardsUpdate201613Member2761400000288080000010370000013030000000.01200000000020000000008355000008495000006955000007092000008.15226.65496.13495.00810.012750.0090.010.005130000000030000000000308000000001300000000540000000532000000001800000000210000000600000000130000000080000000007500000000800000000025000000013000000003000000000030800000000130000000054000000053200000000180000000021000000060000000013000000008000000009000000007500000008000000008000000008000000002500000000.0020.003520.0030.00450.0050.00650.00750.011250.0120.01350.0170.0170.0180.02050.0210.0220.0250.0250.0260.03250.03350.0340.0437500.002250.002750.00100.0000460000000015000000000.047500.04750.05000015000000150000001650000016500001720000165000001650000172000010000002500000000
0000313616
2020-01-01
2020-07-03
0000313616
2020-07-17
0000313616
dhr:A1.35SeniorNotesDue2039Member
2020-01-01
2020-07-03
0000313616
dhr:A1.8SeniorNotesDue2049Member
2020-01-01
2020-07-03
0000313616
dhr:A1.7SeniorNotesDue2024Member
2020-01-01
2020-07-03
0000313616
us-gaap:SeriesBPreferredStockMember
2020-01-01
2020-07-03
0000313616
dhr:FloatingRateSeniorNotesDue2022Member
2020-01-01
2020-07-03
0000313616
dhr:A2.5SeniorNotesDue2030Member
2020-01-01
2020-07-03
0000313616
dhr:A1.7SeniorNotesDue2022Member
2020-01-01
2020-07-03
0000313616
dhr:A1.2SeniorNotesDue2027Member
2020-01-01
2020-07-03
0000313616
us-gaap:CommonStockMember
2020-01-01
2020-07-03
0000313616
dhr:A0.45SeniorNotesDue2028Member
2020-01-01
2020-07-03
0000313616
dhr:A0.2SeniorNotesDue2026Member
2020-01-01
2020-07-03
0000313616
dhr:A0.75SeniorNotesDue2031Member
2020-01-01
2020-07-03
0000313616
us-gaap:SeriesAPreferredStockMember
2020-01-01
2020-07-03
0000313616
dhr:A2.5SeniorNotesDue2025Member
2020-01-01
2020-07-03
0000313616
dhr:A2.1SeniorNotesDue2026Member
2020-01-01
2020-07-03
0000313616
2019-12-31
0000313616
2020-07-03
0000313616
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2020-07-03
0000313616
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2019-12-31
0000313616
us-gaap:PreferredStockMember
2020-07-03
0000313616
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2020-07-03
0000313616
us-gaap:PreferredStockMember
2019-12-31
0000313616
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2019-12-31
2019-12-31
0000313616
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2019-12-31
2019-12-31
0000313616
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2019-12-31
0000313616
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2020-07-03
2020-07-03
0000313616
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2020-07-03
2020-07-03
0000313616
2020-04-04
2020-07-03
0000313616
2019-03-30
2019-06-28
0000313616
2019-01-01
2019-06-28
0000313616
us-gaap:CommonStockMember
2019-03-29
0000313616
us-gaap:AdditionalPaidInCapitalMember
2019-03-30
2019-06-28
0000313616
us-gaap:PreferredStockMember
2019-01-01
2019-06-28
0000313616
us-gaap:AdditionalPaidInCapitalMember
2020-04-03
0000313616
us-gaap:RetainedEarningsMember
2019-12-31
0000313616
us-gaap:CommonStockMember
2019-03-30
2019-06-28
0000313616
us-gaap:PreferredStockMember
2019-06-28
0000313616
srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember
us-gaap:RetainedEarningsMember
2019-12-31
0000313616
us-gaap:NoncontrollingInterestMember
2019-01-01
2019-06-28
0000313616
us-gaap:AdditionalPaidInCapitalMember
2019-06-28
0000313616
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-03-29
0000313616
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-07-03
0000313616
2019-06-28
0000313616
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-04-03
0000313616
us-gaap:RetainedEarningsMember
2020-04-03
0000313616
us-gaap:AdditionalPaidInCapitalMember
2018-12-31
0000313616
us-gaap:RetainedEarningsMember
2020-01-01
2020-07-03
0000313616
us-gaap:NoncontrollingInterestMember
2020-07-03
0000313616
us-gaap:NoncontrollingInterestMember
2019-03-29
0000313616
us-gaap:RetainedEarningsMember
2019-03-29
0000313616
us-gaap:NoncontrollingInterestMember
2019-03-30
2019-06-28
0000313616
us-gaap:PreferredStockMember
2020-04-04
2020-07-03
0000313616
us-gaap:CommonStockMember
2019-06-28
0000313616
us-gaap:NoncontrollingInterestMember
2019-12-31
0000313616
us-gaap:AdditionalPaidInCapitalMember
2020-04-04
2020-07-03
0000313616
us-gaap:PreferredStockMember
2019-03-29
0000313616
us-gaap:CommonStockMember
2020-07-03
0000313616
us-gaap:CommonStockMember
2019-01-01
2019-06-28
0000313616
us-gaap:RetainedEarningsMember
2020-07-03
0000313616
us-gaap:RetainedEarningsMember
2019-06-28
0000313616
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-06-28
0000313616
us-gaap:RetainedEarningsMember
2019-03-30
2019-06-28
0000313616
us-gaap:AdditionalPaidInCapitalMember
2019-12-31
0000313616
srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember
us-gaap:RetainedEarningsMember
2020-04-03
0000313616
us-gaap:AdditionalPaidInCapitalMember
2020-07-03
0000313616
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-12-31
0000313616
us-gaap:NoncontrollingInterestMember
2020-04-04
2020-07-03
0000313616
us-gaap:RetainedEarningsMember
2019-01-01
2019-06-28
0000313616
us-gaap:CommonStockMember
2020-04-04
2020-07-03
0000313616
us-gaap:AdditionalPaidInCapitalMember
2019-03-29
0000313616
us-gaap:CommonStockMember
2019-12-31
0000313616
us-gaap:AdditionalPaidInCapitalMember
2020-01-01
2020-07-03
0000313616
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-03-30
2019-06-28
0000313616
us-gaap:CommonStockMember
2020-04-03
0000313616
us-gaap:RetainedEarningsMember
2020-04-04
2020-07-03
0000313616
us-gaap:NoncontrollingInterestMember
2020-04-03
0000313616
us-gaap:AdditionalPaidInCapitalMember
2019-01-01
2019-06-28
0000313616
us-gaap:PreferredStockMember
2020-04-03
0000313616
us-gaap:PreferredStockMember
2018-12-31
0000313616
srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember
us-gaap:RetainedEarningsMember
2019-03-29
0000313616
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-12-31
0000313616
us-gaap:CommonStockMember
2018-12-31
0000313616
us-gaap:NoncontrollingInterestMember
2020-01-01
2020-07-03
0000313616
us-gaap:PreferredStockMember
2020-01-01
2020-07-03
0000313616
us-gaap:CommonStockMember
2020-01-01
2020-07-03
0000313616
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-01-01
2019-06-28
0000313616
us-gaap:PreferredStockMember
2019-03-30
2019-06-28
0000313616
us-gaap:RetainedEarningsMember
2018-12-31
0000313616
srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember
us-gaap:RetainedEarningsMember
2018-12-31
0000313616
us-gaap:NoncontrollingInterestMember
2018-12-31
0000313616
us-gaap:NoncontrollingInterestMember
2019-06-28
0000313616
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-04-04
2020-07-03
0000313616
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-01-01
2020-07-03
0000313616
2018-12-31
0000313616
us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember
2019-03-29
0000313616
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2019-03-30
2019-06-28
0000313616
us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember
2019-03-30
2019-06-28
0000313616
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2019-03-30
2019-06-28
0000313616
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2020-07-03
0000313616
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2020-07-03
0000313616
us-gaap:AccumulatedTranslationAdjustmentMember
2020-04-04
2020-07-03
0000313616
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2020-04-04
2020-07-03
0000313616
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2020-04-04
2020-07-03
0000313616
us-gaap:AccumulatedTranslationAdjustmentMember
2019-03-30
2019-06-28
0000313616
us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember
2020-04-03
0000313616
us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember
2019-06-28
0000313616
us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember
2020-04-04
2020-07-03
0000313616
us-gaap:AccumulatedTranslationAdjustmentMember
2020-04-03
0000313616
us-gaap:AccumulatedTranslationAdjustmentMember
2020-07-03
0000313616
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2019-03-29
0000313616
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2019-06-28
0000313616
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2019-03-29
0000313616
2020-04-03
0000313616
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2020-04-03
0000313616
2019-03-29
0000313616
us-gaap:AccumulatedTranslationAdjustmentMember
2019-03-29
0000313616
us-gaap:AccumulatedTranslationAdjustmentMember
2019-06-28
0000313616
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2020-04-03
0000313616
us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember
2020-07-03
0000313616
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2019-06-28
0000313616
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-12-31
0000313616
us-gaap:AccumulatedTranslationAdjustmentMember
2019-01-01
2019-06-28
0000313616
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2020-01-01
2020-07-03
0000313616
us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember
2020-01-01
2020-07-03
0000313616
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2019-01-01
2019-06-28
0000313616
us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember
2018-12-31
0000313616
us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember
2019-01-01
2019-06-28
0000313616
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2020-01-01
2020-07-03
0000313616
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2018-12-31
0000313616
us-gaap:AccumulatedTranslationAdjustmentMember
2020-01-01
2020-07-03
0000313616
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2019-01-01
2019-06-28
0000313616
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2019-12-31
0000313616
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2019-12-31
0000313616
us-gaap:AccumulatedTranslationAdjustmentMember
2019-12-31
0000313616
us-gaap:AccumulatedTranslationAdjustmentMember
2018-12-31
0000313616
us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember
2019-12-31
0000313616
srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember
2020-01-01
0000313616
2020-07-03
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementRecurringMember
dhr:EnvironmentalAppliedSolutionsMember
2019-03-30
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:OtherdevelopedmarketsMember
dhr:LifeSciencesMember
2020-04-04
2020-07-03
0000313616
dhr:OtherdevelopedmarketsMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:OtherdevelopedmarketsMember
dhr:EnvironmentalAppliedSolutionsMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:OtherdevelopedmarketsMember
dhr:LifeSciencesMember
2019-03-30
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:DiagnosticsMember
2019-03-30
2019-06-28
0000313616
dhr:WesternEuropeMember
2019-03-30
2019-06-28
0000313616
srt:NorthAmericaMember
2019-03-30
2019-06-28
0000313616
dhr:OtherdevelopedmarketsMember
2019-03-30
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
srt:NorthAmericaMember
dhr:EnvironmentalAppliedSolutionsMember
2019-03-30
2019-06-28
0000313616
dhr:RevenuefromContractwithCustomerMeasurementRecurringMember
2019-03-30
2019-06-28
0000313616
dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember
2019-03-30
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:WesternEuropeMember
dhr:LifeSciencesMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:WesternEuropeMember
dhr:EnvironmentalAppliedSolutionsMember
2019-03-30
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:WesternEuropeMember
dhr:DiagnosticsMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementRecurringMember
dhr:DiagnosticsMember
2019-03-30
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember
dhr:DiagnosticsMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:LifeSciencesMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:HighgrowthmarketsMember
dhr:DiagnosticsMember
2019-03-30
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
srt:NorthAmericaMember
dhr:LifeSciencesMember
2020-04-04
2020-07-03
0000313616
dhr:HighgrowthmarketsMember
2019-03-30
2019-06-28
0000313616
dhr:HighgrowthmarketsMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:OtherdevelopedmarketsMember
dhr:EnvironmentalAppliedSolutionsMember
2019-03-30
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:HighgrowthmarketsMember
dhr:LifeSciencesMember
2019-03-30
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
srt:NorthAmericaMember
dhr:EnvironmentalAppliedSolutionsMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:HighgrowthmarketsMember
dhr:LifeSciencesMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:HighgrowthmarketsMember
dhr:DiagnosticsMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:OtherdevelopedmarketsMember
dhr:DiagnosticsMember
2019-03-30
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:EnvironmentalAppliedSolutionsMember
2019-03-30
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:DiagnosticsMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementRecurringMember
dhr:LifeSciencesMember
2019-03-30
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
srt:NorthAmericaMember
dhr:DiagnosticsMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember
dhr:LifeSciencesMember
2019-03-30
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember
dhr:LifeSciencesMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember
dhr:DiagnosticsMember
2019-03-30
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:OtherdevelopedmarketsMember
dhr:DiagnosticsMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementRecurringMember
dhr:DiagnosticsMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:HighgrowthmarketsMember
dhr:EnvironmentalAppliedSolutionsMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:LifeSciencesMember
2019-03-30
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:EnvironmentalAppliedSolutionsMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
srt:NorthAmericaMember
dhr:LifeSciencesMember
2019-03-30
2019-06-28
0000313616
dhr:RevenuefromContractwithCustomerMeasurementRecurringMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
srt:NorthAmericaMember
dhr:DiagnosticsMember
2019-03-30
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:WesternEuropeMember
dhr:EnvironmentalAppliedSolutionsMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:WesternEuropeMember
dhr:LifeSciencesMember
2019-03-30
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementRecurringMember
dhr:LifeSciencesMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember
dhr:EnvironmentalAppliedSolutionsMember
2019-03-30
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementRecurringMember
dhr:EnvironmentalAppliedSolutionsMember
2020-04-04
2020-07-03
0000313616
dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember
2020-04-04
2020-07-03
0000313616
srt:NorthAmericaMember
2020-04-04
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:HighgrowthmarketsMember
dhr:EnvironmentalAppliedSolutionsMember
2019-03-30
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:WesternEuropeMember
dhr:DiagnosticsMember
2019-03-30
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember
dhr:EnvironmentalAppliedSolutionsMember
2020-04-04
2020-07-03
0000313616
dhr:WesternEuropeMember
2020-04-04
2020-07-03
0000313616
dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:OtherdevelopedmarketsMember
dhr:LifeSciencesMember
2020-01-01
2020-07-03
0000313616
dhr:RevenuefromContractwithCustomerMeasurementRecurringMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
srt:NorthAmericaMember
dhr:EnvironmentalAppliedSolutionsMember
2020-01-01
2020-07-03
0000313616
srt:NorthAmericaMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:DiagnosticsMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementRecurringMember
dhr:LifeSciencesMember
2019-01-01
2019-06-28
0000313616
dhr:WesternEuropeMember
2019-01-01
2019-06-28
0000313616
dhr:WesternEuropeMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember
dhr:EnvironmentalAppliedSolutionsMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
srt:NorthAmericaMember
dhr:LifeSciencesMember
2020-01-01
2020-07-03
0000313616
dhr:HighgrowthmarketsMember
2019-01-01
2019-06-28
0000313616
dhr:HighgrowthmarketsMember
2020-01-01
2020-07-03
0000313616
dhr:OtherdevelopedmarketsMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:OtherdevelopedmarketsMember
dhr:DiagnosticsMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:DiagnosticsMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:EnvironmentalAppliedSolutionsMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:HighgrowthmarketsMember
dhr:DiagnosticsMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:OtherdevelopedmarketsMember
dhr:LifeSciencesMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
srt:NorthAmericaMember
dhr:DiagnosticsMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:WesternEuropeMember
dhr:LifeSciencesMember
2019-01-01
2019-06-28
0000313616
dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember
dhr:DiagnosticsMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:LifeSciencesMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:HighgrowthmarketsMember
dhr:EnvironmentalAppliedSolutionsMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
srt:NorthAmericaMember
dhr:EnvironmentalAppliedSolutionsMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:WesternEuropeMember
dhr:EnvironmentalAppliedSolutionsMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember
dhr:EnvironmentalAppliedSolutionsMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:EnvironmentalAppliedSolutionsMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
srt:NorthAmericaMember
dhr:DiagnosticsMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementRecurringMember
dhr:DiagnosticsMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember
dhr:DiagnosticsMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:WesternEuropeMember
dhr:DiagnosticsMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementRecurringMember
dhr:EnvironmentalAppliedSolutionsMember
2019-01-01
2019-06-28
0000313616
srt:NorthAmericaMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:HighgrowthmarketsMember
dhr:LifeSciencesMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:WesternEuropeMember
dhr:LifeSciencesMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember
dhr:LifeSciencesMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:WesternEuropeMember
dhr:EnvironmentalAppliedSolutionsMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:OtherdevelopedmarketsMember
dhr:DiagnosticsMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
srt:NorthAmericaMember
dhr:LifeSciencesMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementRecurringMember
dhr:LifeSciencesMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:OtherdevelopedmarketsMember
dhr:EnvironmentalAppliedSolutionsMember
2020-01-01
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementRecurringMember
dhr:DiagnosticsMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:LifeSciencesMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:HighgrowthmarketsMember
dhr:EnvironmentalAppliedSolutionsMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementNonrecurringMember
dhr:LifeSciencesMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:HighgrowthmarketsMember
dhr:LifeSciencesMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:OtherdevelopedmarketsMember
dhr:EnvironmentalAppliedSolutionsMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:WesternEuropeMember
dhr:DiagnosticsMember
2019-01-01
2019-06-28
0000313616
dhr:OtherdevelopedmarketsMember
2020-01-01
2020-07-03
0000313616
dhr:RevenuefromContractwithCustomerMeasurementRecurringMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:HighgrowthmarketsMember
dhr:DiagnosticsMember
2019-01-01
2019-06-28
0000313616
us-gaap:OperatingSegmentsMember
dhr:RevenuefromContractwithCustomerMeasurementRecurringMember
dhr:EnvironmentalAppliedSolutionsMember
2020-01-01
2020-07-03
0000313616
dhr:CytivaMember
2020-03-31
0000313616
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2020-01-01
2020-07-03
0000313616
us-gaap:PensionPlansDefinedBenefitMember
2020-01-01
2020-07-03
0000313616
dhr:CytivaMember
2020-03-31
2020-03-31
0000313616
dhr:CytivaMember
us-gaap:AcquisitionRelatedCostsMember
2019-01-01
2019-06-28
0000313616
2019-01-01
2019-12-31
0000313616
dhr:CytivaMember
us-gaap:AcquisitionRelatedCostsMember
2020-01-01
2020-07-03
0000313616
2020-04-30
2020-04-30
0000313616
dhr:CytivaMember
2019-03-01
2019-03-01
0000313616
dhr:CytivaMember
us-gaap:FairValueAdjustmentToInventoryMember
2019-03-30
2019-06-28
0000313616
dhr:CytivaMember
us-gaap:FairValueAdjustmentToInventoryMember
2019-01-01
2019-06-28
0000313616
dhr:CytivaMember
2019-01-01
2019-12-31
0000313616
dhr:CytivaMember
2019-06-29
2019-12-31
0000313616
dhr:CytivaMember
us-gaap:AcquisitionRelatedCostsMember
2019-03-30
2019-06-28
0000313616
dhr:CytivaMember
2020-01-01
2020-07-03
0000313616
us-gaap:CustomerRelationshipsMember
2020-07-03
0000313616
us-gaap:TrademarksAndTradeNamesMember
2020-07-03
0000313616
us-gaap:CustomerRelationshipsMember
2019-12-31
0000313616
us-gaap:PatentedTechnologyMember
2019-12-31
0000313616
us-gaap:PatentedTechnologyMember
2020-07-03
0000313616
us-gaap:TrademarksAndTradeNamesMember
2019-12-31
0000313616
us-gaap:OperatingSegmentsMember
dhr:LifeSciencesMember
2019-12-31
0000313616
us-gaap:OperatingSegmentsMember
dhr:EnvironmentalAppliedSolutionsMember
2019-12-31
0000313616
us-gaap:OperatingSegmentsMember
dhr:LifeSciencesMember
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:EnvironmentalAppliedSolutionsMember
2020-07-03
0000313616
us-gaap:OperatingSegmentsMember
dhr:DiagnosticsMember
2019-12-31
0000313616
us-gaap:OperatingSegmentsMember
dhr:DiagnosticsMember
2020-07-03
0000313616
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2020-07-03
0000313616
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-12-31
0000313616
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2020-07-03
0000313616
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-12-31
0000313616
us-gaap:FairValueInputsLevel3Member
2019-12-31
0000313616
us-gaap:FairValueInputsLevel2Member
2019-12-31
0000313616
us-gaap:FairValueInputsLevel1Member
2019-12-31
0000313616
us-gaap:FairValueInputsLevel3Member
2020-07-03
0000313616
us-gaap:FairValueInputsLevel1Member
2020-07-03
0000313616
us-gaap:FairValueInputsLevel2Member
2020-07-03
0000313616
dhr:ZeroCouponLYONSDue2021Member
us-gaap:ConvertibleDebtMember
2020-01-01
2020-07-03
0000313616
us-gaap:SeniorNotesMember
2020-04-08
2020-04-08
0000313616
us-gaap:RevolvingCreditFacilityMember
dhr:Superseded364DayFacilityMember
us-gaap:ShortTermDebtMember
2020-06-05
0000313616
us-gaap:CommercialPaperMember
2020-07-03
0000313616
us-gaap:RevolvingCreditFacilityMember
dhr:Superseded364DayFacilityMember
us-gaap:ShortTermDebtMember
2020-04-07
2020-04-07
0000313616
us-gaap:RevolvingCreditFacilityMember
dhr:FiveYearFacilityMember
us-gaap:LongTermDebtMember
2020-05-15
2020-05-15
0000313616
us-gaap:RevolvingCreditFacilityMember
dhr:FiveYearFacilityMember
us-gaap:LongTermDebtMember
2020-03-24
2020-03-24
0000313616
us-gaap:SeniorNotesMember
2020-03-30
2020-03-30
0000313616
us-gaap:RevolvingCreditFacilityMember
dhr:FiveYearFacilityMember
us-gaap:LongTermDebtMember
2020-04-01
2020-07-03
0000313616
us-gaap:CommercialPaperMember
2020-07-03
2020-07-03
0000313616
us-gaap:RevolvingCreditFacilityMember
dhr:FiveYearFacilityMember
us-gaap:LongTermDebtMember
2020-06-05
0000313616
us-gaap:RevolvingCreditFacilityMember
dhr:FiveYearFacilityMember
us-gaap:LongTermDebtMember
2020-03-24
2020-03-31
0000313616
us-gaap:RevolvingCreditFacilityMember
dhr:A364DayFacilityMember
us-gaap:ShortTermDebtMember
2020-06-05
0000313616
dhr:A1.7SeniorNotesDue2024Member
us-gaap:SeniorNotesMember
2020-04-08
0000313616
dhr:A2.5SeniorNotesDue2030Member
us-gaap:SeniorNotesMember
2020-03-30
2020-03-30
0000313616
dhr:A2.1SeniorNotesDue2026Member
us-gaap:SeniorNotesMember
2020-03-30
2020-03-30
0000313616
dhr:A2.5SeniorNotesDue2030Member
us-gaap:SeniorNotesMember
2020-04-08
2020-04-08
0000313616
dhr:A1.7SeniorNotesDue2024Member
us-gaap:SeniorNotesMember
2020-04-08
2020-04-08
0000313616
dhr:A2.5SeniorNotesDue2030Member
us-gaap:SeniorNotesMember
2020-04-08
0000313616
dhr:A1.7SeniorNotesDue2024Member
us-gaap:SeniorNotesMember
2020-03-30
0000313616
dhr:A1.7SeniorNotesDue2024Member
us-gaap:SeniorNotesMember
2020-03-30
2020-03-30
0000313616
dhr:A2.1SeniorNotesDue2026Member
us-gaap:SeniorNotesMember
2020-03-30
0000313616
dhr:A2.5SeniorNotesDue2030Member
us-gaap:SeniorNotesMember
2020-03-30
0000313616
dhr:A2.1SeniorNotesDue2026Member
us-gaap:SeniorNotesMember
2020-04-08
0000313616
dhr:A2.1SeniorNotesDue2026Member
us-gaap:SeniorNotesMember
2020-04-08
2020-04-08
0000313616
dhr:A1.2SeniorNotesDue2027Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:A1.125BondsDue2028Member
us-gaap:BondsMember
2020-07-03
0000313616
dhr:A4.375SeniorNotesDue2045Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:A2.1SeniorNotesDue2026Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:A0.352SeniorNotesDue2021Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:A1.35SeniorNotesDue2039Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:A1.8SeniorNotesDue2049Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:A1.2SeniorNotesDue2027Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:A2.1SeniorNotesDue2026Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:USDollarDenominatedCommercialPaperMember
us-gaap:CommercialPaperMember
2019-12-31
0000313616
dhr:A1.7SeniorNotesDue2024Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:A1.7SeniorNotesDue2022Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:A3.25SeniorUnsecuredNotesDue2039Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:EuroDenominatedCommercialPaperMember
us-gaap:CommercialPaperMember
2019-12-31
0000313616
dhr:A0.3SeniorNotesDue2027Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:OtherMember
2020-07-03
0000313616
dhr:A4.375SeniorNotesDue2045Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:A1.7SeniorNotesDue2024Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:A0.5BondsDue2023Member
us-gaap:BondsMember
2019-12-31
0000313616
us-gaap:RevolvingCreditFacilityMember
dhr:FiveYearFacilityMember
2019-12-31
0000313616
dhr:A2.5SeniorNotesDue2025Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:A0.3SeniorNotesDue2027Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:A0.75SeniorNotesDue2031Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:A0.65SeniorNotesDue2032Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:A3.4SeniorUnsecuredNotesDue2049Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:ZeroCouponLYONSDue2021Member
us-gaap:ConvertibleDebtMember
2020-07-03
0000313616
us-gaap:RevolvingCreditFacilityMember
dhr:FiveYearFacilityMember
2020-07-03
0000313616
dhr:A2.2SeniorUnsecuredNotesDue2024Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:ZeroCouponLYONSDue2021Member
us-gaap:ConvertibleDebtMember
2019-12-31
0000313616
dhr:A2.2SeniorUnsecuredNotesDue2024Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:A2.6SeniorUnsecuredNotesDue2029Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:A1.7SeniorNotesDue2022Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:A0.45SeniorNotesDue2028Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:A2.05SeniorUnsecuredNotesDue2022Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:A2.6SeniorUnsecuredNotesDue2029Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:A1.125BondsDue2028Member
us-gaap:BondsMember
2019-12-31
0000313616
dhr:OtherMember
2019-12-31
0000313616
dhr:A1.8SeniorNotesDue2049Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:A2.5SeniorNotesDue2030Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:USDollarDenominatedCommercialPaperMember
us-gaap:CommercialPaperMember
2020-07-03
0000313616
dhr:A0.2SeniorNotesDue2026Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:A3.4SeniorUnsecuredNotesDue2049Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:A0.75SeniorNotesDue2031Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:A3.35SeniorNotesDue2025Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:A3.35SeniorNotesDue2025Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:A0.352SeniorNotesDue2021Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:A2.05SeniorUnsecuredNotesDue2022Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:A0.5BondsDue2023Member
us-gaap:BondsMember
2020-07-03
0000313616
dhr:A2.5SeniorNotesDue2030Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:EuroDenominatedCommercialPaperMember
us-gaap:CommercialPaperMember
2020-07-03
0000313616
dhr:A3.25SeniorUnsecuredNotesDue2039Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:A0.2SeniorNotesDue2026Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:FloatingRateSeniorNotesDue2022Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:A2.5SeniorNotesDue2025Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:A0.65SeniorNotesDue2032Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:A1.35SeniorNotesDue2039Member
us-gaap:SeniorNotesMember
2019-12-31
0000313616
dhr:A0.45SeniorNotesDue2028Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
dhr:FloatingRateSeniorNotesDue2022Member
us-gaap:SeniorNotesMember
2020-07-03
0000313616
us-gaap:RevolvingCreditFacilityMember
dhr:Superseded364DayFacilityMember
us-gaap:ShortTermDebtMember
2020-05-15
2020-05-15
0000313616
srt:MaximumMember
us-gaap:RevolvingCreditFacilityMember
dhr:A364DayFacilityMember
us-gaap:ShortTermDebtMember
us-gaap:EurodollarMember
2020-06-05
2020-06-05
0000313616
us-gaap:RevolvingCreditFacilityMember
dhr:A364DayFacilityMember
us-gaap:ShortTermDebtMember
us-gaap:FederalFundsEffectiveSwapRateMember
2020-06-05
2020-06-05
0000313616
srt:MinimumMember
us-gaap:RevolvingCreditFacilityMember
dhr:A364DayFacilityMember
us-gaap:ShortTermDebtMember
2020-06-05
0000313616
srt:MaximumMember
us-gaap:RevolvingCreditFacilityMember
dhr:A364DayFacilityMember
us-gaap:ShortTermDebtMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2020-06-05
2020-06-05
0000313616
us-gaap:RevolvingCreditFacilityMember
dhr:A364DayFacilityMember
us-gaap:ShortTermDebtMember
us-gaap:EurodollarMember
2020-06-05
2020-06-05
0000313616
srt:MaximumMember
us-gaap:RevolvingCreditFacilityMember
dhr:A364DayFacilityMember
us-gaap:ShortTermDebtMember
2020-06-05
2020-06-05
0000313616
srt:MinimumMember
us-gaap:RevolvingCreditFacilityMember
dhr:A364DayFacilityMember
us-gaap:ShortTermDebtMember
us-gaap:EurodollarMember
2020-06-05
2020-06-05
0000313616
srt:MaximumMember
us-gaap:RevolvingCreditFacilityMember
dhr:A364DayFacilityMember
us-gaap:ShortTermDebtMember
2020-06-05
0000313616
srt:MinimumMember
us-gaap:RevolvingCreditFacilityMember
dhr:A364DayFacilityMember
us-gaap:ShortTermDebtMember
us-gaap:LondonInterbankOfferedRateLIBORMember
2020-06-05
2020-06-05
0000313616
srt:MinimumMember
us-gaap:RevolvingCreditFacilityMember
dhr:A364DayFacilityMember
us-gaap:ShortTermDebtMember
2020-06-05
2020-06-05
0000313616
us-gaap:ForeignExchangeContractMember
us-gaap:NetInvestmentHedgingMember
2020-07-03
0000313616
dhr:ForeignCurrencyDenominatedDebtMember
us-gaap:NetInvestmentHedgingMember
2020-01-01
2020-07-03
0000313616
us-gaap:ForeignExchangeContractMember
us-gaap:NetInvestmentHedgingMember
2019-06-28
0000313616
dhr:ForeignCurrencyDenominatedDebtMember
us-gaap:NetInvestmentHedgingMember
2019-01-01
2019-06-28
0000313616
dhr:ForeignCurrencyDenominatedDebtMember
us-gaap:NetInvestmentHedgingMember
2019-03-30
2019-06-28
0000313616
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
2020-01-01
2020-07-03
0000313616
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
2020-07-03
0000313616
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
2019-06-28
0000313616
dhr:ForeignCurrencyDenominatedDebtMember
us-gaap:NetInvestmentHedgingMember
2020-04-04
2020-07-03
0000313616
us-gaap:ForeignExchangeContractMember
us-gaap:NetInvestmentHedgingMember
2019-03-30
2019-06-28
0000313616
us-gaap:ForeignExchangeContractMember
us-gaap:NetInvestmentHedgingMember
2020-01-01
2020-07-03
0000313616
us-gaap:ForeignExchangeContractMember
us-gaap:NetInvestmentHedgingMember
2019-01-01
2019-06-28
0000313616
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
2019-03-30
2019-06-28
0000313616
us-gaap:ForeignExchangeContractMember
us-gaap:NetInvestmentHedgingMember
2020-04-04
2020-07-03
0000313616
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
2019-01-01
2019-06-28
0000313616
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
2020-04-04
2020-07-03
0000313616
us-gaap:ForeignExchangeContractMember
us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember
2020-04-04
2020-07-03
0000313616
us-gaap:ForeignExchangeContractMember
us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember
2020-01-01
2020-07-03
0000313616
us-gaap:InterestRateSwapMember
us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember
2020-04-04
2020-07-03
0000313616
us-gaap:OtherNoncurrentAssetsMember
us-gaap:NetInvestmentHedgingMember
2019-12-31
0000313616
us-gaap:LongTermDebtMember
us-gaap:NetInvestmentHedgingMember
2019-12-31
2019-12-31
0000313616
us-gaap:AccountsPayableAndAccruedLiabilitiesMember
us-gaap:NetInvestmentHedgingMember
2020-07-03
0000313616
us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember
us-gaap:NetInvestmentHedgingMember
2019-12-31
0000313616
us-gaap:AccountsPayableAndAccruedLiabilitiesMember
us-gaap:NetInvestmentHedgingMember
2019-12-31
0000313616
us-gaap:LongTermDebtMember
us-gaap:NetInvestmentHedgingMember
2020-07-03
2020-07-03
0000313616
us-gaap:OtherNoncurrentAssetsMember
us-gaap:NetInvestmentHedgingMember
2020-07-03
0000313616
us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember
us-gaap:NetInvestmentHedgingMember
2020-07-03
0000313616
us-gaap:InterestRateSwapMember
us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember
2020-01-01
2020-07-03
0000313616
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2019-01-01
2019-06-28
0000313616
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2020-04-04
2020-07-03
0000313616
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2019-03-30
2019-06-28
0000313616
us-gaap:CostOfSalesMember
2019-03-30
2019-06-28
0000313616
us-gaap:CostOfSalesMember
2020-04-04
2020-07-03
0000313616
us-gaap:CostOfSalesMember
2020-01-01
2020-07-03
0000313616
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2020-01-01
2020-07-03
0000313616
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2019-01-01
2019-06-28
0000313616
us-gaap:CostOfSalesMember
2019-01-01
2019-06-28
0000313616
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2019-03-30
2019-06-28
0000313616
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2020-04-04
2020-07-03
0000313616
us-gaap:ForeignCountryMember
2020-07-03
0000313616
us-gaap:ForeignCountryMember
2013-12-10
0000313616
2017-12-22
2017-12-31
0000313616
us-gaap:ForeignCountryMember
2019-08-27
0000313616
us-gaap:ForeignCountryMember
2019-12-16
0000313616
2017-01-01
2017-12-21
0000313616
2012-01-01
2015-12-31
0000313616
srt:MaximumMember
2020-01-01
2020-07-03
0000313616
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2020-05-31
0000313616
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2020-05-01
2020-05-31
0000313616
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2019-03-01
2019-03-01
0000313616
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2019-03-01
0000313616
us-gaap:CommonStockMember
2020-05-31
0000313616
us-gaap:CommonStockMember
2019-03-01
0000313616
us-gaap:CommonStockMember
2019-03-01
2019-03-01
0000313616
us-gaap:RestrictedStockUnitsRSUMember
2020-07-03
2020-07-03
0000313616
us-gaap:CommonStockMember
2020-05-01
2020-05-31
0000313616
us-gaap:CommonStockMember
2020-05-01
2020-05-31
0000313616
us-gaap:EmployeeStockOptionMember
2020-07-03
0000313616
us-gaap:EmployeeStockOptionMember
2020-07-03
2020-07-03
0000313616
2013-07-16
0000313616
us-gaap:RestrictedStockUnitsRSUMember
2020-07-03
0000313616
us-gaap:EmployeeStockOptionMember
2019-01-01
2019-06-28
0000313616
us-gaap:EmployeeStockOptionMember
2020-04-04
2020-07-03
0000313616
us-gaap:EmployeeStockOptionMember
2019-03-30
2019-06-28
0000313616
us-gaap:RestrictedStockUnitsRSUMember
2020-01-01
2020-07-03
0000313616
us-gaap:RestrictedStockUnitsRSUMember
2020-04-04
2020-07-03
0000313616
us-gaap:RestrictedStockUnitsRSUMember
2019-03-30
2019-06-28
0000313616
us-gaap:EmployeeStockOptionMember
2020-01-01
2020-07-03
0000313616
us-gaap:RestrictedStockUnitsRSUMember
2019-01-01
2019-06-28
0000313616
srt:MaximumMember
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2020-07-03
0000313616
srt:MaximumMember
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2020-05-31
0000313616
srt:MinimumMember
us-gaap:SeriesBPreferredStockMember
us-gaap:PreferredStockMember
2020-05-31
0000313616
srt:MinimumMember
us-gaap:SeriesAPreferredStockMember
us-gaap:PreferredStockMember
2020-07-03
0000313616
us-gaap:CorporateNonSegmentMember
2019-01-01
2019-06-28
0000313616
us-gaap:CorporateNonSegmentMember
2020-01-01
2020-07-03
0000313616
us-gaap:CorporateNonSegmentMember
2019-03-30
2019-06-28
0000313616
us-gaap:CorporateNonSegmentMember
2020-04-04
2020-07-03
0000313616
us-gaap:CorporateNonSegmentMember
2019-12-31
0000313616
us-gaap:CorporateNonSegmentMember
2020-07-03
xbrli:shares
xbrli:pure
iso4217:USD
xbrli:shares
iso4217:USD
iso4217:CHF
iso4217:JPY
iso4217:EUR
dhr:Business
iso4217:DKK
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________________________________
FORM 10-Q
________________________________________________________
(Mark One)
|
| |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended July 3, 2020
OR
|
| |
☐ | TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 001-08089
DANAHER CORPORATION
(Exact name of registrant as specified in its charter)
|
| | | |
Delaware | | 59-1995548 |
(State of Incorporation) | | (I.R.S. Employer Identification Number) |
| |
2200 Pennsylvania Avenue, N.W., Suite 800W | | 20037-1701 |
Washington, | DC | |
(Address of Principal Executive Offices) | | (Zip Code) |
Registrant’s telephone number, including area code: 202-828-0850
|
| | |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Common stock, $0.01 par value | DHR | New York Stock Exchange |
4.75% Mandatory Convertible Preferred Stock, Series A, without par value | DHR.PRA | New York Stock Exchange |
5.00% Mandatory Convertible Preferred Stock, Series B, without par value | DHR.PRB | New York Stock Exchange |
Floating Rate Senior Notes due 2022 | DHR F 06/30/22 | New York Stock Exchange |
1.700% Senior Notes due 2022 | DHR 1.7 01/04/22 | New York Stock Exchange |
1.700% Senior Notes due 2024 | DHR 1.7 03/30/24 | New York Stock Exchange |
2.500% Senior Notes due 2025 | DHR 2.5 07/08/25 | New York Stock Exchange |
0.200% Senior Notes due 2026 | DHR 0.2 03/18/26 | New York Stock Exchange |
2.100% Senior Notes due 2026 | DHR 2.1 09/30/26 | New York Stock Exchange |
1.200% Senior Notes due 2027 | DHR 1.2 06/30/27 | New York Stock Exchange |
0.450% Senior Notes due 2028 | DHR 0.45 03/18/28 | New York Stock Exchange |
2.500% Senior Notes due 2030 | DHR 2.5 03/30/30 | New York Stock Exchange |
0.750% Senior Notes due 2031 | DHR 0.75 09/18/31 | New York Stock Exchange |
1.350% Senior Notes due 2039 | DHR 1.35 09/18/39 | New York Stock Exchange |
1.800% Senior Notes due 2049 | DHR 1.8 09/18/49 | New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
| | | | | | |
Large Accelerated Filer | | ☒ | | Accelerated Filer | | ☐ |
| | | |
Non-accelerated Filer | | ☐ | | Smaller Reporting Company | | ☐ |
| | | | | | |
Emerging Growth Company | | ☐ | | | | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒
The number of shares of common stock outstanding at July 17, 2020 was 709,408,837.
DANAHER CORPORATION
INDEX
FORM 10-Q
|
| | |
| | Page |
PART I - | FINANCIAL INFORMATION | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
PART II - | OTHER INFORMATION | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
DANAHER CORPORATION AND SUBSIDIARIES
CONSOLIDATED CONDENSED BALANCE SHEETS
($ and shares in millions, except per share amount)
(unaudited)
|
| | | | | | | |
| July 3, 2020 | | December 31, 2019 |
ASSETS | | | |
Current assets: | | | |
Cash and equivalents | $ | 5,539.3 |
| | $ | 19,912.3 |
|
Trade accounts receivable, less allowance for doubtful accounts of $130.3 and $103.7, respectively | 3,378.4 |
| | 3,191.4 |
|
Inventories: | | | |
Finished goods | 1,406.2 |
| | 833.5 |
|
Work in process | 475.4 |
| | 284.9 |
|
Raw materials | 711.3 |
| | 509.9 |
|
Total inventories | 2,592.9 |
| | 1,628.3 |
|
Prepaid expenses and other current assets | 833.2 |
| | 864.6 |
|
Total current assets | 12,343.8 |
| | 25,596.6 |
|
Property, plant and equipment, net of accumulated depreciation of $2,880.8 and $2,761.4, respectively | 2,972.9 |
| | 2,302.0 |
|
Other long-term assets | 2,280.1 |
| | 1,720.8 |
|
Goodwill | 33,227.1 |
| | 22,712.5 |
|
Other intangible assets, net | 20,444.5 |
| | 9,749.7 |
|
Total assets | $ | 71,268.4 |
| | $ | 62,081.6 |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | |
Current liabilities: | | | |
Notes payable and current portion of long-term debt | $ | 17.2 |
| | $ | 212.4 |
|
Trade accounts payable | 1,598.6 |
| | 1,514.4 |
|
Accrued expenses and other liabilities | 3,984.1 |
| | 3,205.3 |
|
Total current liabilities | 5,599.9 |
| | 4,932.1 |
|
Other long-term liabilities | 7,025.6 |
| | 5,350.9 |
|
Long-term debt | 22,370.0 |
| | 21,516.7 |
|
Stockholders’ equity: | | | |
Preferred stock, without par value, 15.0 million shares authorized; 1.65 million shares of 4.75% Mandatory Convertible Preferred Stock, Series A, issued and outstanding as of July 3, 2020 and December 31, 2019; 1.72 million shares of 5.00% Mandatory Convertible Preferred Stock, Series B, issued and outstanding as of July 3, 2020 and no shares issued or outstanding as of December 31, 2019 | 3,267.7 |
| | 1,599.6 |
|
Common stock - $0.01 par value, 2.0 billion shares authorized; 849.5 million issued and 709.2 million outstanding as of July 3, 2020; 835.5 million issued and 695.5 million outstanding as of December 31, 2019 | 8.5 |
| | 8.4 |
|
Additional paid-in capital | 9,475.1 |
| | 7,564.6 |
|
Retained earnings | 25,373.5 |
| | 24,166.3 |
|
Accumulated other comprehensive income (loss) | (1,863.1 | ) | | (3,068.3 | ) |
Total Danaher stockholders’ equity | 36,261.7 |
| | 30,270.6 |
|
Noncontrolling interests | 11.2 |
| | 11.3 |
|
Total stockholders’ equity | 36,272.9 |
| | 30,281.9 |
|
Total liabilities and stockholders’ equity | $ | 71,268.4 |
| | $ | 62,081.6 |
|
See the accompanying Notes to the Consolidated Condensed Financial Statements.
DANAHER CORPORATION AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF EARNINGS
($ and shares in millions, except per share amounts)
(unaudited)
|
| | | | | | | | | | | | | | | | |
| Three-Month Period Ended | | Six-Month Period Ended | |
| July 3, 2020 | | June 28, 2019 | | July 3, 2020 | | June 28, 2019 | |
Sales | $ | 5,297.4 |
| | $ | 4,444.5 |
| | $ | 9,640.5 |
| | $ | 8,664.7 |
| |
Cost of sales | (2,444.8 | ) | | (1,960.7 | ) | | (4,345.1 | ) | | (3,826.0 | ) | |
Gross profit | 2,852.6 |
| | 2,483.8 |
| | 5,295.4 |
| | 4,838.7 |
| |
Operating costs: | | | | | | | | |
Selling, general and administrative expenses | (1,685.4 | ) | | (1,390.0 | ) | | (3,143.7 | ) | | (2,757.7 | ) | |
Research and development expenses | (322.6 | ) | | (282.1 | ) | | (609.6 | ) | | (549.6 | ) | |
Operating profit | 844.6 |
| | 811.7 |
| | 1,542.1 |
| | 1,531.4 |
| |
Nonoperating income (expense): | | | | | | | | |
Other (expense) income, net | (0.7 | ) | | 5.0 |
| | (2.2 | ) | | 10.1 |
| |
Gain on sale of product lines | 454.6 |
| | — |
| | 454.6 |
| | — |
| |
Interest expense | (78.6 | ) | | (19.7 | ) | | (126.0 | ) | | (40.2 | ) | |
Interest income | 1.0 |
| | 26.2 |
| | 63.5 |
| | 41.9 |
| |
Earnings from continuing operations before income taxes | 1,220.9 |
| | 823.2 |
| | 1,932.0 |
| | 1,543.2 |
| |
Income taxes | (293.6 | ) | | (146.8 | ) | | (409.6 | ) | | (534.5 | ) | |
Net earnings from continuing operations | 927.3 |
| | 676.4 |
| | 1,522.4 |
| | 1,008.7 |
| |
Earnings from discontinued operations, net of income taxes | — |
| | 54.9 |
| | — |
| | 56.4 |
| |
Net earnings | 927.3 |
| | 731.3 |
| | 1,522.4 |
| | 1,065.1 |
| |
Mandatory convertible preferred stock dividends | (34.6 | ) | | (22.7 | ) | | (54.2 | ) | | (29.2 | ) | |
Net earnings attributable to common stockholders | $ | 892.7 |
| | $ | 708.6 |
| | $ | 1,468.2 |
| | $ | 1,035.9 |
| |
Net earnings per common share from continuing operations: | | | | | | | | |
Basic | $ | 1.27 |
| | $ | 0.91 |
| | $ | 2.09 |
| (b) | $ | 1.37 |
| |
Diluted | $ | 1.24 |
| | $ | 0.90 |
| | $ | 2.06 |
| (b) | $ | 1.36 |
| |
Net earnings per common share from discontinued operations: | | | | | | | | |
Basic | $ | — |
| | $ | 0.08 |
| | $ | — |
| | $ | 0.08 |
| |
Diluted | $ | — |
| | $ | 0.08 |
| | $ | — |
| | $ | 0.08 |
| |
Net earnings per common share: | | | | | | | | |
Basic | $ | 1.27 |
| | $ | 0.99 |
| | $ | 2.09 |
| (b) | $ | 1.45 |
| |
Diluted | $ | 1.24 |
| | $ | 0.97 |
| (a) | $ | 2.06 |
| (b) | $ | 1.43 |
| (a) |
Average common stock and common equivalent shares outstanding: | | |
| | | | | |
Basic | 705.1 |
| | 717.6 |
| | 701.1 |
| | 712.6 |
| |
Diluted | 718.2 |
| | 727.9 |
| | 713.1 |
| | 723.2 |
| |
(a)
(b)
See the accompanying Notes to the Consolidated Condensed Financial Statements.
DANAHER CORPORATION AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME
($ in millions)
(unaudited)
|
| | | | | | | | | | | | | | | |
| Three-Month Period Ended | | Six-Month Period Ended |
| July 3, 2020 | | June 28, 2019 | | July 3, 2020 | | June 28, 2019 |
Net earnings | $ | 927.3 |
| | $ | 731.3 |
| | $ | 1,522.4 |
| | $ | 1,065.1 |
|
Other comprehensive income (loss), net of income taxes: | | | | | | | |
Foreign currency translation adjustments | 1,076.7 |
| | (46.5 | ) | | 922.8 |
| | (57.3 | ) |
Pension and postretirement plan benefit adjustments | 7.9 |
| | 4.6 |
| | 16.1 |
| | 10.0 |
|
Unrealized gain on available-for-sale securities adjustments | 0.4 |
| | 0.5 |
| | 1.0 |
| | 0.9 |
|
Cash flow hedge adjustments | (156.8 | ) | | (6.8 | ) | | 265.3 |
| | (6.8 | ) |
Total other comprehensive income (loss), net of income taxes | 928.2 |
| | (48.2 | ) | | 1,205.2 |
| | (53.2 | ) |
Comprehensive income | $ | 1,855.5 |
| | $ | 683.1 |
| | $ | 2,727.6 |
| | $ | 1,011.9 |
|
See the accompanying Notes to the Consolidated Condensed Financial Statements.
DANAHER CORPORATION AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS’ EQUITY
($ in millions)
(unaudited)
|
| | | | | | | | | | | | | | | |
| Three-Month Period Ended | | Six-Month Period Ended |
| July 3, 2020 | | June 28, 2019 | | July 3, 2020 | | June 28, 2019 |
Preferred stock: | | | | | | | |
Balance, beginning of period | $ | 1,599.6 |
| | $ | 1,599.6 |
| | $ | 1,599.6 |
| | $ | — |
|
Issuance of Mandatory Convertible Preferred Stock | 1,668.1 |
| | — |
| | 1,668.1 |
| | 1,599.6 |
|
Balance, end of period | $ | 3,267.7 |
| | $ | 1,599.6 |
| | $ | 3,267.7 |
| | $ | 1,599.6 |
|
Common stock: | | | | | | | |
Balance, beginning of period | $ | 8.4 |
| | $ | 8.3 |
| | $ | 8.4 |
| | $ | 8.2 |
|
Issuance of common stock | 0.1 |
| | — |
| | 0.1 |
| | 0.1 |
|
Balance, end of period | $ | 8.5 |
| | $ | 8.3 |
| | $ | 8.5 |
| | $ | 8.3 |
|
Additional paid-in capital: | | | | | | | |
Balance, beginning of period | $ | 7,629.8 |
| | $ | 7,376.3 |
| | $ | 7,564.6 |
| | $ | 5,834.3 |
|
Common stock-based award activity | 106.8 |
| | 93.5 |
| | 171.3 |
| | 175.6 |
|
Common stock issued in connection with LYONs’ conversions, including tax benefit of $3.0, $3.5, $3.0 and $8.2, respectively | 10.1 |
| | 12.8 |
| | 10.8 |
| | 29.6 |
|
Issuance of common stock | 1,728.4 |
| | — |
| | 1,728.4 |
| | 1,443.1 |
|
Balance, end of period | $ | 9,475.1 |
| | $ | 7,482.6 |
| | $ | 9,475.1 |
| | $ | 7,482.6 |
|
Retained earnings: | | | | | | | |
Balance, beginning of period | $ | 24,608.6 |
| | $ | 25,368.5 |
| | $ | 24,166.3 |
| | $ | 25,163.0 |
|
Adoption of accounting standards | — |
| | — |
| | (7.6 | ) | | — |
|
Net earnings | 927.3 |
| | 731.3 |
| | 1,522.4 |
| | 1,065.1 |
|
Dividends declared for common stock | (127.8 | ) | | (122.1 | ) | | (253.4 | ) | | (243.9 | ) |
Mandatory Convertible Preferred Stock cumulative dividends | (34.6 | ) | | (22.7 | ) | | (54.2 | ) | | (29.2 | ) |
Balance, end of period | $ | 25,373.5 |
| | $ | 25,955.0 |
| | $ | 25,373.5 |
| | $ | 25,955.0 |
|
Accumulated other comprehensive income (loss): | | | | | | | |
Balance, beginning of period | $ | (2,791.3 | ) | | $ | (2,796.1 | ) | | $ | (3,068.3 | ) | | $ | (2,791.1 | ) |
Other comprehensive income (loss) | 928.2 |
| | (48.2 | ) | | 1,205.2 |
| | (53.2 | ) |
Balance, end of period | $ | (1,863.1 | ) | | $ | (2,844.3 | ) | | $ | (1,863.1 | ) | | $ | (2,844.3 | ) |
Noncontrolling interests: | | | | | | | |
Balance, beginning of period | $ | 11.3 |
| | $ | 12.1 |
| | $ | 11.3 |
| | $ | 12.3 |
|
Change in noncontrolling interests | (0.1 | ) | | (0.1 | ) | | (0.1 | ) | | (0.3 | ) |
Balance, end of period | $ | 11.2 |
| | $ | 12.0 |
| | $ | 11.2 |
| | $ | 12.0 |
|
Total stockholders’ equity, end of period | $ | 36,272.9 |
| | $ | 32,213.2 |
| | $ | 36,272.9 |
| | $ | 32,213.2 |
|
See the accompanying Notes to the Consolidated Condensed Financial Statements.
DANAHER CORPORATION AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
($ in millions)
(unaudited)
|
| | | | | | | |
| Six-Month Period Ended |
| July 3, 2020 | | June 28, 2019 |
Cash flows from operating activities: | | | |
Net earnings | $ | 1,522.4 |
| | $ | 1,065.1 |
|
Less: earnings from discontinued operations, net of income taxes | — |
| | 56.4 |
|
Net earnings from continuing operations | 1,522.4 |
| | 1,008.7 |
|
Noncash items: | | | |
Depreciation | 304.4 |
| | 280.7 |
|
Amortization | 470.5 |
| | 313.7 |
|
Stock-based compensation expense | 91.8 |
| | 76.5 |
|
Pretax gain on sale of product lines | (454.6 | ) | | — |
|
Change in trade accounts receivable, net | 274.3 |
| | 20.4 |
|
Change in inventories | (70.4 | ) | | (169.8 | ) |
Change in trade accounts payable | (160.3 | ) | | (22.6 | ) |
Change in prepaid expenses and other assets | 62.2 |
| | 223.8 |
|
Change in accrued expenses and other liabilities | 230.7 |
| | 37.7 |
|
Total operating cash provided by continuing operations | 2,271.0 |
| | 1,769.1 |
|
Total operating cash (used in) provided by discontinued operations | (7.0 | ) | | 105.7 |
|
Net operating cash provided by operating activities | 2,264.0 |
| | 1,874.8 |
|
Cash flows from investing activities: | | | |
Cash paid for acquisitions | (20,735.6 | ) | | (326.6 | ) |
Payments for additions to property, plant and equipment | (287.9 | ) | | (294.4 | ) |
Proceeds from sales of property, plant and equipment | 0.8 |
| | 11.7 |
|
Payments for purchases of investments | (127.8 | ) | | (92.3 | ) |
Proceeds from sale of product lines | 809.8 |
| | — |
|
All other investing activities | 11.4 |
| | 16.1 |
|
Total investing cash used in continuing operations | (20,329.3 | ) | | (685.5 | ) |
Total investing cash used in discontinued operations | — |
| | (41.9 | ) |
Net operating cash used in investing activities | (20,329.3 | ) | | (727.4 | ) |
Cash flows from financing activities: | | | |
Proceeds from the issuance of common stock in connection with stock-based compensation | 69.1 |
| | 83.0 |
|
Proceeds from the sale of common stock, net of issuance costs | 1,728.5 |
| | 1,443.2 |
|
Proceeds from the sale of preferred stock, net of issuance costs | 1,668.1 |
| | 1,599.6 |
|
Payment of dividends | (283.1 | ) | | (233.9 | ) |
Net (repayments of) proceeds from borrowings (maturities of 90 days or less) | (3,377.1 | ) | | 599.6 |
|
Net proceeds from borrowings (maturities longer than 90 days) | 7,691.3 |
| | — |
|
Net repayments of borrowings (maturities longer than 90 days) | (3,750.0 | ) | | (3.9 | ) |
All other financing activities | (1.3 | ) | | (4.8 | ) |
Net operating cash provided by financing activities | 3,745.5 |
| | 3,482.8 |
|
Effect of exchange rate changes on cash and equivalents | (53.2 | ) | | 15.6 |
|
Net change in cash and equivalents | (14,373.0 | ) | | 4,645.8 |
|
Beginning balance of cash and equivalents | 19,912.3 |
| | 787.8 |
|
Ending balance of cash and equivalents | $ | 5,539.3 |
| | $ | 5,433.6 |
|
Supplemental disclosures: | | | |
Cash interest payments | $ | 117.7 |
| | $ | 49.2 |
|
Cash income tax payments | 333.1 |
| | 196.1 |
|
See the accompanying Notes to the Consolidated Condensed Financial Statements.
DANAHER CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(unaudited)
NOTE 1. GENERAL
The Consolidated Condensed Financial Statements included herein have been prepared by Danaher Corporation (“Danaher” or the “Company”) without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In this quarterly report, the terms “Danaher” or the “Company” refer to Danaher Corporation, Danaher Corporation and its consolidated subsidiaries, (unless otherwise indicated or the context otherwise requires) or the consolidated subsidiaries of Danaher Corporation, as the context requires. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted pursuant to SEC rules and regulations; however, the Company believes that the disclosures are adequate to make the information presented not misleading. The Consolidated Condensed Financial Statements included herein should be read in conjunction with the financial statements as of and for the year ended December 31, 2019 and the Notes thereto included in the Company’s 2019 Annual Report on Form 10-K filed on February 21, 2020 (the “2019 Annual Report”).
In the opinion of the Company, the accompanying financial statements contain all adjustments (consisting of only normal recurring accruals) necessary to present fairly the financial position of the Company as of July 3, 2020 and December 31, 2019, its results of operations for the three and six-month periods ended July 3, 2020 and June 28, 2019 and its cash flows for each of the six-month periods then ended.
Accounting Standards Recently Adopted—In August 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2018-13, Fair Value Measurement (Topic 820), which modifies the disclosures on fair value measurements by removing the requirement to disclose the amount and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy and the policy for timing of such transfers. The ASU expands the disclosure requirements for Level 3 fair value measurements, primarily focused on changes in unrealized gains and losses included in other comprehensive income (loss). The ASU is effective for public entities for fiscal years beginning after December 15, 2019, with early adoption permitted. On January 1, 2020, the Company adopted the ASU and the ASU did not have a significant impact on the Company’s Consolidated Condensed Financial Statements. Refer to Note 6 for the Company’s fair value measurement disclosures.
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses rather than incurred losses to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. The ASU is effective for public entities for fiscal years beginning after December 15, 2019, with early adoption permitted. In November 2018, the FASB issued ASU No. 2018-19, Codification Improvements to Topic 326, Financial Instruments—Credit Losses, which provided additional implementation guidance on the previously issued ASU. On January 1, 2020, the Company adopted the ASU using the modified retrospective transition method. The Company recorded a net decrease to beginning retained earnings of $8 million as of January 1, 2020 due to the cumulative impact of adopting Topic 326. The impact to retained earnings was primarily the result of an increase in the Company’s allowance for doubtful accounts as a result of Topic 326’s requirement to use a forward-looking approach based on expected losses rather than incurred losses to estimate credit losses on certain types of financial instruments, including trade receivables. As a result of the adoption of the ASU, the Company’s allowance for doubtful accounts as of July 3, 2020 reflects the Company’s best estimate of the expected future losses for its accounts receivables based on the current economic conditions; however, as a result of the uncertainty caused by the coronavirus (COVID-19) pandemic and other factors, these estimates may change and future actual losses may differ from the Company’s estimates. The Company will continue to monitor economic conditions and will revise the estimates of the expected future losses for accounts receivable as necessary.
Accounting Standards Not Yet Adopted—In August 2018, the FASB issued ASU No. 2018-14, Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans, which amends ASC 715, Compensation—Retirement Benefits, to add, remove and clarify disclosure requirements related to defined benefit pension and other postretirement plans. The ASU is effective for public entities for fiscal years beginning after December 15, 2020, with early adoption permitted. Management has not yet completed its assessment of the impact of the new standard on the Company’s financial statements.
Operating Leases—As of July 3, 2020 and December 31, 2019, operating lease right-of-use assets where the Company was the lessee were $870 million and $764 million, respectively, and are included within other long-term assets in the accompanying Consolidated Condensed Balance Sheets. The associated operating lease liabilities were $894 million and $797 million as of
July 3, 2020 and December 31, 2019, respectively, and are included in accrued expenses and other liabilities and other long-term liabilities.
Accumulated Other Comprehensive Income (Loss)—Accumulated other comprehensive income (loss) refers to certain gains and losses that under U.S. GAAP are included in comprehensive income (loss) but are excluded from net earnings as these amounts are initially recorded as an adjustment to stockholders’ equity. The changes in accumulated other comprehensive income (loss) by component are summarized below ($ in millions). Foreign currency translation adjustments generally relate to indefinite investments in non-U.S. subsidiaries, as well as the impact from the Company’s hedges of its net investment in foreign operations, including the Company’s cross-currency swap derivatives, net of any income tax impacts.
|
| | | | | | | | | | | | | | | | | | | |
| Foreign Currency Translation Adjustments | | Pension & Postretirement Plan Benefit Adjustments | | Unrealized Gain (Loss) on Available-For-Sale Securities Adjustments | | Cash Flow Hedge Adjustments | | Total |
For the Three-Month Period Ended July 3, 2020: | | |
Balance, April 3, 2020 | $ | (2,327.2 | ) | | $ | (773.3 | ) | | $ | (0.1 | ) | | $ | 309.3 |
| | $ | (2,791.3 | ) |
Other comprehensive income (loss) before reclassifications: | | | | | | | | | |
Increase (decrease) | 1,070.6 |
| | — |
| | 0.5 |
| | (354.3 | ) | | 716.8 |
|
Income tax impact | 6.1 |
| | — |
| | (0.1 | ) | | 74.4 |
| | 80.4 |
|
Other comprehensive income (loss) before reclassifications, net of income taxes | 1,076.7 |
| | — |
| | 0.4 |
| | (279.9 | ) | | 797.2 |
|
Amounts reclassified from accumulated other comprehensive income (loss): | | | | | | | | | |
Increase | — |
| | 10.4 |
| (a) | — |
| | 155.8 |
| (b) | 166.2 |
|
Income tax impact | — |
| | (2.5 | ) | | — |
| | (32.7 | ) | | (35.2 | ) |
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes | — |
| | 7.9 |
| | — |
| | 123.1 |
| | 131.0 |
|
Net current period other comprehensive income (loss), net of income taxes | 1,076.7 |
| | 7.9 |
| | 0.4 |
| | (156.8 | ) | | 928.2 |
|
Balance, July 3, 2020 | $ | (1,250.5 | ) | | $ | (765.4 | ) | | $ | 0.3 |
| | $ | 152.5 |
| | $ | (1,863.1 | ) |
| | | | | | | | | |
For the Three-Month Period Ended June 28, 2019: | | |
Balance, March 29, 2019 | $ | (2,108.9 | ) | | $ | (685.7 | ) | | $ | (1.5 | ) | | $ | — |
| | $ | (2,796.1 | ) |
Other comprehensive income (loss) before reclassifications: | | | | | | | | | |
(Decrease) increase | (51.9 | ) | | — |
| | 0.7 |
| | (8.9 | ) | | (60.1 | ) |
Income tax impact | 5.4 |
| | — |
| | (0.2 | ) | | 2.1 |
| | 7.3 |
|
Other comprehensive income (loss) before reclassifications, net of income taxes | (46.5 | ) | | — |
| | 0.5 |
| | (6.8 | ) | | (52.8 | ) |
Amounts reclassified from accumulated other comprehensive income (loss): | | | | | | | | | |
Increase | — |
| | 6.1 |
| (a) | — |
| | — |
| | 6.1 |
|
Income tax impact | — |
| | (1.5 | ) | | — |
| | — |
| | (1.5 | ) |
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes | — |
| | 4.6 |
| | — |
| | — |
| | 4.6 |
|
Net current period other comprehensive income (loss), net of income taxes | (46.5 | ) | | 4.6 |
| | 0.5 |
| | (6.8 | ) | | (48.2 | ) |
Balance, June 28, 2019 | $ | (2,155.4 | ) | | $ | (681.1 | ) | | $ | (1.0 | ) | | $ | (6.8 | ) | | $ | (2,844.3 | ) |
(a) This accumulated other comprehensive income (loss) component is included in the computation of net periodic pension cost. Refer to Notes 9 and 11 for additional details.
(b) Reflects reclassification to earnings related to hedges of certain long-term debt (refer to Note 8 for additional details).
|
| | | | | | | | | | | | | | | | | | | |
| Foreign Currency Translation Adjustments | | Pension & Postretirement Plan Benefit Adjustments | | Unrealized Gain (Loss) on Available-For-Sale Securities Adjustments | | Cash Flow Hedge Adjustments | | Total |
For the Six-Month Period Ended July 3, 2020: | | |
Balance, December 31, 2019 | $ | (2,173.3 | ) | | $ | (781.5 | ) | | $ | (0.7 | ) | | $ | (112.8 | ) | | $ | (3,068.3 | ) |
Other comprehensive income (loss) before reclassifications: | | | | | | | | | |
Increase | 939.1 |
| | — |
| | 1.2 |
| | 296.5 |
| | 1,236.8 |
|
Income tax impact | (16.3 | ) | | — |
| | (0.2 | ) | | (44.5 | ) | | (61.0 | ) |
Other comprehensive income (loss) before reclassifications, net of income taxes | 922.8 |
| | — |
| | 1.0 |
| | 252.0 |
| | 1,175.8 |
|
Amounts reclassified from accumulated other comprehensive income (loss): | | | | | | | | | |
Increase | — |
| | 21.2 |
| (a) | — |
| | 17.0 |
| (b) | 38.2 |
|
Income tax impact | — |
| | (5.1 | ) | | — |
| | (3.7 | ) | | |